Extract from M&A Insights

M&A Insights is our fully-fledged M&A platform for teams operating in the Nordics and DACH countries, enabling clients to identify and qualify opportunities well in advance of any structured process.
Leo Pharma invests USD 0.5m in Microbiome technology
April 13, 2018

The medical company Leo Pharma invests USD 0.5m in the American company Naked Biome, which develops treatments for skin diseases. As part of the agreement, Leo Pharma will be part of the Naked Biome Advisory Board focusing on counseling in clinical plans and formulation development, according to the press release.

ⓘ This story was originally featured in our daily M&A Newsletter - a part of M&A Insights.
Our insights have been covered by: